Published • loading... • Updated
Medicare’s Drug-Pricing Proposal Carries A Hidden Cost
CMS says treating newer drugs like older versions would shorten companies’ window to recoup post-approval investments and could curb follow-on innovation.
Summary by Forbes
3 Articles
3 Articles
Explaining the Medicare Drug-Plan Subsidy That Trump Is Ending
Q: Is President Donald Trump really cutting Medicare subsidies? A: The Trump administration recently announced that it is ending a temporary subsidy that has reduced premiums for Medicare Part D standalone prescription drug plans. The subsidy, originally slated to run through at least 2027, was put into place by the Biden administration to offset expected premium increases after major changes to the Part D benefit. Analysts say some Medicare ben…
The US President does not decelerate against the price differentials of pharmaceuticals between the United States and Europe, threatening a confrontation
Coverage Details
Total News Sources3
Leaning Left0Leaning Right0Center2Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
